Aligos Therapeutics ALGS
NASDAQ ALGS
$2.10 +0.12 (+6.06%)
At close: Nov 13, 2026 · 4:00 PM EST

Aligos Therapeutics (ALGS) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Aligos Therapeutics (ALGS) reported Return on Capital Employed [ROCE] of -195.17% for Q3 2026, down 108.66 percentage points from -86.52% a year earlier but up 17.75 percentage points from the prior quarter.

Analysis

Aligos Therapeutics (ALGS) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Aligos Therapeutics posted Return on Capital Employed [ROCE] of -151.49%, down 51.40 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for five consecutive years, with a five-year change of -95.79 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -100.09% in FY2024 (-29.70 pp), -70.39% in FY2023 (-8.59 pp), -61.80% in FY2022 (-1.09 pp) and -60.71% in FY2021 (-5.00 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -212.92% in Q2 2026 and a high of -61.03% in Q4 2021.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last three quarters, with an average year-over-year change of -39.49 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q4 2025 (a gain of 42.06 percentage points); the low point was Q2 2026 (a drop of 148.81 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -212.92% (Q2 2026), -179.75% (Q1 2026) and -112.92% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 Aligos Therapeutics 21.97 Mn -314.86 Mn - -195.17%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -195.17%
Jun 30, 2026 -212.92%
Mar 31, 2026 -179.75%
Dec 31, 2025 -112.92%
Sep 30, 2025 -86.52%
Jun 30, 2025 -64.12%
Mar 31, 2025 -94.43%
Dec 31, 2024 -154.99%
Sep 30, 2024 -121.79%
Jun 30, 2024 -98.67%
Mar 31, 2024 -71.38%
Dec 31, 2023 -92.98%
Sep 30, 2023 -115.35%
Jun 30, 2023 -97.67%
Mar 31, 2023 -80.97%
Dec 31, 2022 -79.82%
Sep 30, 2022 -79.05%
Jun 30, 2022 -77.02%
Mar 31, 2022 -74.98%
Dec 31, 2021 -61.03%
API Access

Aligos Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ALGS&period=max&api_key=YOUR_API_KEY